Sangamo Therapeutics Inc. buy Truist Financial Co.
Start price
15.08.23
/
50%
€0.93
Target price
15.08.24
€6.40
Performance (%)
-60.65%
Price
19.07.24
€0.37
Summary
This prediction is currently active. The BUY prediction by Truist_Financial_Co_ for Sangamo Therapeutics Inc. is performing very badly with a performance of -60.65%. This prediction currently runs until 15.08.24. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sangamo Therapeutics Inc. | -12.188% | -12.188% |
iShares Core DAX® | -3.033% | 0.651% |
iShares Nasdaq 100 | -3.554% | -3.007% |
iShares Nikkei 225® | -3.938% | 1.935% |
iShares S&P 500 | -1.517% | -0.602% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Sangamo Bioscienes diskutieren
Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its price target lowered by analysts at Truist Financial Co. from $8.00 to $7.00. They now have a "buy" rating on the stock.
Ratings data for SGMO provided by MarketBeat